R. Chapurlat

786 total citations
23 papers, 531 citations indexed

About

R. Chapurlat is a scholar working on Orthopedics and Sports Medicine, Molecular Biology and Oncology. According to data from OpenAlex, R. Chapurlat has authored 23 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Orthopedics and Sports Medicine, 8 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in R. Chapurlat's work include Bone health and osteoporosis research (14 papers), Bone health and treatments (8 papers) and Bone Metabolism and Diseases (7 papers). R. Chapurlat is often cited by papers focused on Bone health and osteoporosis research (14 papers), Bone health and treatments (8 papers) and Bone Metabolism and Diseases (7 papers). R. Chapurlat collaborates with scholars based in France, Belgium and United States. R. Chapurlat's co-authors include Patrick Garnero, P.D. Delmas, Elisabeth Sornay‐Rendu, Pierre D. Delmas, P. J. Meunier, Stéphanie Boutroy, M. Arlot, Bruno Claustrat, Nicolas Vilayphiou and Anne Fouque-Aubert and has published in prestigious journals such as Annals of the Rheumatic Diseases, Bone and Osteoporosis International.

In The Last Decade

R. Chapurlat

21 papers receiving 514 citations

Peers

R. Chapurlat
P. Geusens Belgium
Halley Rogers United States
T. Okano Japan
JD Adachi Canada
Sanchita Agarwal United States
Karen D. Barrow United States
A. Rezqi Morocco
R. Chapurlat
Citations per year, relative to R. Chapurlat R. Chapurlat (= 1×) peers Martha C. Castaño‐Betancourt

Countries citing papers authored by R. Chapurlat

Since Specialization
Citations

This map shows the geographic impact of R. Chapurlat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Chapurlat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Chapurlat more than expected).

Fields of papers citing papers by R. Chapurlat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Chapurlat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Chapurlat. The network helps show where R. Chapurlat may publish in the future.

Co-authorship network of co-authors of R. Chapurlat

This figure shows the co-authorship network connecting the top 25 collaborators of R. Chapurlat. A scholar is included among the top collaborators of R. Chapurlat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Chapurlat. R. Chapurlat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Viprey, Marie, et al.. (2020). Interventions to improve osteoporosis care: a systematic review and meta-analysis. Osteoporosis International. 31(3). 429–446. 20 indexed citations
2.
Paccou, Julien, et al.. (2020). AB0815 CHANGES IN BODY COMPOSITION, BONE MINERAL DENSITY AND BONE REMODELING MARKERS DURING INTERLEUKIN 12/23 INHIBITION IN PSORIATIC ARTHRITIS. Annals of the Rheumatic Diseases. 79. 1710–1710. 1 indexed citations
3.
Sornay‐Rendu, Elisabeth, F. Duboeuf, Stéphanie Boutroy, & R. Chapurlat. (2016). Muscle mass is associated with incident fracture in postmenopausal women: The OFELY study. Bone. 94. 108–113. 31 indexed citations
4.
Warriner, Amy H., Ryan C. Outman, F H Hooven, et al.. (2013). Osteoporosis Medication Adherence: Reasons For Stopping and Not Starting. Oxford University Research Archive (ORA) (University of Oxford). 65. 1 indexed citations
5.
Palacios, Santiago, Sydney Lou Bonnick, R. Chapurlat, et al.. (2013). OP0247 Effects of Odanacatib on BMD and Safety in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated with Alendronate– a Randomized Placebo-Controlled Trial. Annals of the Rheumatic Diseases. 72. A136–A136. 1 indexed citations
6.
Reginster, Jean‐Yves, Nathalie Franchimont, R. Chapurlat, et al.. (2012). Relationship Between Changes in Bone Mineral Density and Incidence of Fracture with 6 Years of Denosumab Treatment. Open Repository and Bibliography (University of Liège). 1 indexed citations
7.
Chapurlat, R., Socrates E. Papapoulos, Jacques P. Brown, et al.. (2012). Treatment of postmenopausal women with osteoporosis for six years with denosumab : three-year results from the freedom extension. Open Repository and Bibliography (University of Liège). 1 indexed citations
8.
Papapoulos, Socrates E., Jacques P. Brown, R. Chapurlat, et al.. (2012). DENOSUMAB TREATMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS FOR 6 YEARS: RESULTS FROM THE FIRST 3 YEARS OF THE FREEDOM EXTENSION. Open Repository and Bibliography (University of Liège). 2 indexed citations
9.
Roux, Christian, F H Hooven, Stephen H. Gehlbach, et al.. (2012). Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women. Osteoporosis International. 23(12). 2863–2871. 77 indexed citations
10.
Christen, Patrik, et al.. (2012). Local changes due to bone remodelling are triggered by mechanical loading. Data Archiving and Networked Services (DANS). 1 indexed citations
11.
Bone, Henry G., R. Chapurlat, Cesar Libanati, et al.. (2011). Safety observations from denosumab long-term extension and cross-over studies in postmenopausal women with osteoporosis. Open Repository and Bibliography (University of Liège). 3 indexed citations
12.
Orwoll, Eric, Bente Langdahl, R. Chapurlat, et al.. (2011). A phase 3 study of the efficacy and safety of Denosumab in men with low bone mineral density : design of the ADAMO. Open Repository and Bibliography (University of Liège). 1 indexed citations
13.
Reginster, Jean‐Yves, R. Chapurlat, H K Genant, et al.. (2011). EFFICACY AND SAFETY OF STRONTIUM RANELATE IN THE TREATMENT OF KNEE OSTEOARTHRITIS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED INTERNATIONAL TRIAL. Osteoporosis International. 22. 1 indexed citations
14.
Boutroy, Stéphanie, Nicolas Vilayphiou, Annie Varennes, et al.. (2011). Association of bone microarchitecture with parathyroid hormone concentration and calcium intake in men: the STRAMBO study. European Journal of Endocrinology. 165(1). 151–159. 33 indexed citations
15.
Chapurlat, R., Socrates E. Papapoulos, Henry G. Bone, et al.. (2010). Long-term denosumab treatment of postmenopausal women with osteoporosis: results from the first year extension study of the FREEDOM trial. Open Repository and Bibliography (University of Liège). 2 indexed citations
16.
Seeman, Ego, R. Chapurlat, Albert T. Cheung, et al.. (2010). RISEDRONATE REDUCES MICRO-STRUCTURAL DETERIORATION OF CORTICAL BONE ACCOMPANYING MENOPAUSE. Osteoporosis International. 21. 4 indexed citations
17.
Fouque-Aubert, Anne, Stéphanie Boutroy, Hubert Marotte, et al.. (2010). Assessment of hand bone loss in rheumatoid arthritis by high-resolution peripheral quantitative CT. Annals of the Rheumatic Diseases. 69(9). 1671–1676. 85 indexed citations
18.
Gineyts, Évelyne, Olivier Borel, R. Chapurlat, & Patrick Garnero. (2010). Quantification of immature and mature collagen crosslinks by liquid chromatography–electrospray ionization mass spectrometry in connective tissues. Journal of Chromatography B. 878(19). 1449–1454. 39 indexed citations
19.
Chapurlat, R., Patrick Garnero, Elisabeth Sornay‐Rendu, et al.. (2000). Longitudinal Study of Bone Loss in Pre- and Perimenopausal Women: Evidence for Bone Loss in Perimenopausal Women. Osteoporosis International. 11(6). 493–498. 104 indexed citations
20.
Chapurlat, R., et al.. (2000). Serum type I collagen breakdown product (serum CTX) predicts hip fracture risk in elderly women:. Bone. 27(2). 283–286. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026